Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.88 USD | +6.52% | +26.41% | +126.80% |
Mar. 06 | Transcript : Inovio Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 06, 2024 | |
Mar. 06 | Inovio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+126.80% | 324M | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |
- Stock
- Equities
- Stock Inovio Pharmaceuticals, Inc. - Nasdaq
- News Inovio Pharmaceuticals, Inc.
- Earnings Flash (INO) INOVIO PHARMACEUTICALS Posts Q3 Revenue $291.7M